medigraphic.com

2021, Número 1

Rev Cubana Neurol Neurocir 2021; 11 (1)


Manifestaciones neurológicas en la COVID-19

Céspedes RHR, Rodríguez BDJ, Céspedes RHA, Céspedes RRA

Idioma: Español
Referencias bibliográficas: 57
Paginas: 1-18
Archivo PDF: 288.65 Kb.


RESUMEN

Objetivo: Describir los síntomas y signos neurológicos en la infección por SARS-CoV2.
Adquisición de la evidencia: Se realizó una búsqueda bibliográfica, en inglés, español y portugués, en las bases de datos PubMed y LILACs. Se seleccionaron 114 artículos publicados de enero de 2020 a 2 de julio de 2020, que abordaron las manifestaciones clínicas y complicaciones neurológicas en la infección por el SARS-CoV2. Se utilizaron como términos de búsqueda: COVID-19, SARS-CoV2, CoV-2, en combinación con los términos: sistema nervioso, manifestaciones neurológicas, síntomas neurológicos, síntomas neuro - psiquiátricos, daño neurológico, desmielinización, complicaciones neurológicas, encefalopatía, enfermedad cerebrovascular, encefalitis.
Resultados: Los síntomas y signos neurológicos son frecuentes en pacientes con COVID-19. Las manifestaciones clínicas del sistema nervioso central, sistema nervioso periférico y músculo-esquelético se observan tanto en la COVID-19 en su forma no severa como en la severa. Cefalea, alteraciones del gusto y el olfato, y mialgias son referidos en las formas no severa y severa de la enfermedad. Los trastornos de la conciencia, delirio y signos piramidales son característicos de la COVID-19 severa. Se presenta, en la fase avanzada de la enfermedad, una clínica compatible con afectación del nervio periférico, disautonomía y miopatías.
Conclusiones: El panorama epidemiológico actual exige que los médicos de asistencia sean conocedores del amplio espectro de síntomas y signos neurológicos de la COVID19 para un diagnóstico precoz de la enfermedad y las complicaciones. La inclusión de la práctica neurológica en los protocolos diagnóstico - terapéuticos permite optimizar la atención a pacientes con COVID-19.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Johns Hopkins University COVID-19 Map. Johns Hopkins Coronavirus Resource Center [citado: 07/10/2020]. Disponible en: https://coronavirus.jhu.edu/map.html

  2. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22. Doi: 10.1016/j.bbi.2020.03.031

  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. Doi: 10.1016/S0140-6736(20)30183-5

  4. Jiang F, Deng L, Zhang L, Cai Y, Cheung C W, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med. 2020;35(5):1545-9. Doi: 10.1007/s11606-020-05762-w

  5. Du Y Z, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan a Retrospective Observational Study. Am J Respir Crit Care Med. 2020;201(11):1372-9. Doi: 10.1164/rccm.202003-0543OC

  6. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020 Jun 4;382(23):2268-70. Doi: 10.1056/NEJMc2008597.

  7. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. 2020. Doi: https://doi.org/10.1101/2020.02.22.20026500

  8. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang, C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-2. Doi: 10.1016/S2213-2600(20)30076-X.

  9. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020 Aug;88:945-6. Doi: 10.1016/j.bbi.2020.04.017.

  10. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395:507-13. Doi: 10.1016/S0140-6736(20)30211-7

  11. Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARSCoV2 Infection. Brain Behav. Immun. 2020;88:11-6. Doi: https://doi.org/10.1016/j.bbi.2020.05.037

  12. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with Novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323:1061. Doi: 10.1001/jama. 2020.1585

  13. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. Doi: 10.1136/bmj.m1091

  14. Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80:639-45. Doi: 10.1016/j.jinf.2020. 03.019

  15. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020;26(8):1063-8. Doi: 10.1016/j.cmi.2020.03.032

  16. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen A, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):1060-70. Doi: 10.1212/WNL.0000000000009937

  17. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurological Sciences. 2020;41:1991-5. Doi: https://doi.org/10.1007/s10072-020-04547-7

  18. Ortiz-Brizuela E, Villanueva-Reza M, Gonzalez-Lara MF, Tamez-Torres KM, Roman-Montes CM, Diaz-Mejia BA, et al. Clinical and epidemiological characteristic of patients diagnosed with COVID-19 in a tertiary care center in Mexico city: A prospective cohort study. Rev Invest Clin. 2020;72(3):165-77.

  19. Nalleballe K, Onteddu SR, Sharma R, Dandu V, Brown A, Jasti M, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain, Behavior, and Immunity. 2020;88:71-4. Doi: https://doi.org/10.1016/j.bbi.2020.06.020

  20. Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royera PY, Lepillerb Q, Gendrin V, et al. Features of anosmia in COVID-19. Med Mal Infect. 2020;50(5):436-9. Doi: 10.1016/j.medmal.2020.04.006.

  21. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID- 19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251-61(2020). Doi: 10.1007/s00405-020-05965-1

  22. Tsivgoulis G, Fragkou PC, Delides A, Karofylakis E, Dimopoulou D, Sfikakis PP, et al. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID‑19). Journal of Neurology. 2020;267:2193-5(2020). Doi: https://doi.org/10.1007/s00415-020-09935-9

  23. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020 Jul;87:34-9. Doi: 10.1016/j.bbi.2020.04.027.

  24. Kang L, Ma S, Chen M, Yang J, Wang Y, Li R, et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: a cross-sectional study. Brain Behav. Immun. 2020;87:11-17. Doi: https://doi.org/10.1016/j.bbi.2020.03.028

  25. Varatharaj A, Thomas N, Ellul M A, Davies NWS, Pollak TA, Tenorio EL, et al Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875-82. Doi: https://doi.org/10.1016/S2215-0366(20)30287-X

  26. Scullen T, Keen J, Mathkour M, Dumont AS, Kahn L. Coronavirus 2019 (COVID-19) Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience. World Neurosurg. 2020;141:e437-e446. Doi: https://doi.org/10.1016/j.wneu.2020.05.192

  27. Beyrouti R, Adams ME, Benjamin L, Cohen H, Framer S F, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889-91.

  28. Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli G L, Bnà C, et al. Stroke in patients with SARS‑CoV‑2 infection: case series. Journal of Neurology. 2020;267:2185-92(2020). Doi: https://doi.org/10.1007/s00415-020-09885-2

  29. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav. Immun. 2020;87:115-9. Doi: https://doi.org/10.1016/j.bbi.2020.04.077

  30. Dogana L, Kayab D, Sarikaya T, Zengin R, Dincer A, Akinci I O, et al. Plasmapheresis treatment in COVID-19–related autoinmune meningoencephalitis: Case series. Brain Behav. Immun. 2020;87:155-8. Doi: https://doi.org/10.1016/j.bbi.2020.05.022

  31. Chaumont H, San‑Galli A, Martino F, Couratier C, Joguet G, Carles M, et al. Mixed central and peripheral nervous system disorders in severe SARS‑CoV‑2 infection. J Neurol. 2020;267:3121-7(2020). Doi: https://doi.org/10.1007/s00415-020-09986-y

  32. D`Anna J, Kwan J, Brown Z, Halse O, Jamil S, Kalladka D, et al. Characteristics and clinical course of Covid‑19 patients admitted with acute stroke. Journal of Neurology. 2020;267:3161-5. Doi: https://doi.org/10.1007/s00415-020-10012-4

  33. Xiong W, Mu J, Guo J, Lu L, Liu D, Luo J, et al. New onset neurologic events in people with COVID-19 infection in three regions in China. Neurology. 2020;95(11). Doi: 10.1212/WNL.0000000000010034

  34. Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Kramer S, et al. Acute transverse myelitis after COVID‑19 pneumonia. J Neurol. 2020;267:2196-7. Doi: https://doi.org/10.1007/s00415-020-09934-w

  35. Al Ketbi R, Al Nuaimi D, Al Mulla M, Al Talai N, Samir M, Kumar N. Acute Myelitis as a Neurological Complication of Covid-19: A Case Report and MRI Findings. Radiology Case Reports. 2020;15(9):1591-5. Doi: https://doi.org/10.1016/j.radcr.2020.06.001

  36. Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain, Behavior & Inmunity - Health. 2020;5:100091. Doi: https://doi.org/10.1016/j.bbih.2020.100091

  37. Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D, et al. Generalized myoclonus in COVID-19. Neurology. 2020;95(6). Doi: http://doi.org/10.1212/WNL.0000000000009829

  38. Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure. 2020;78:109-12. Doi: https://doi.org/10.1016/j.seizure.2020.04.009

  39. Fasano A, Cavallieri F, Canali E, Valzania F. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020;41:1651-3. Doi: http://doi.org/10.1007/s10072-020-04460-z

  40. Brun G, Hak J, Coze S, Kaphan E, Carvelli J, Girard N, et al. COVID-19 – White matter and globus pallidum lesions demyelination or small-vessel vasculitis? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e777. Doi: http://doi.org/10.1212/NXI.0000000000000777

  41. Manganotti P, Pesavento V, Buoite Stella A, Bonzi L, Campagnolo E, Bellavista G, et al. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. Journal of NeuroVirology. 2020;26:605-6. Doi: https://doi.org/10.1007/s13365-020-00858-9

  42. Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barr´e syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7:e741. Doi: 10.1212/NXI.0000000000000741

  43. Rana S, Lima AA, Chandra R, Valeriano J, Desai T, Freiberg W, et al. Novel Coronavirus (COVID-19)-Associated Guillain–Barre syndrome: case report. Case Report. J Clin Neuromuscul Dis. 2020 Jun;21(4):240-2. Doi: 10.1097/CND.0000000000000309.

  44. Frazi MA, Ayromlou H, Jahanbakhsh N, Bavil PH, Janzadeh A, Shayan FK. Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report. Journal of Neuroimmunology. 2020;346:577294. Doi: https://doi.org/10.1016/j.jneuroim.2020.577294

  45. Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, et al. Guillain-Barr´e syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7:e785. Doi: 10.1212/NXI.0000000000000785

  46. Lascano AM, Epiney JB, Coen M, Serratrice J, Bernard-Valnet R, Lalive PH, et al. SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome. Eur J Neurol. 2020;27(9):1751-3. Doi: 10.1111/ENE.14369

  47. Su XW, Palka SV, Rao RR, Chen FS, Brackney CR and Cambi F. SARS-CoV-2–associated Guillain-Barré syndrome with dysautonomia. Muscle & Nerve. 2020;62(2):E48-E49. Doi: 10.1002/mus.26988

  48. Ghiasvand F, Ghadimi M, Ghadimi F, Safarpour S, Hosseinzadeh R, Seyed Alinaghi SA. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19). IDCases. 2020;20:e00815. Doi: https://doi.org/10.1016/j.idcr.2020.e00815

  49. Coen M, Jeanson G, Culebras Almeida A, Hubers A, Stierlin F, Najjar I, et al. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav. Immun. 2020;87:111-2. Doi: https://doi.org/10.1016/j.bbi.2020.04.074

  50. Scheidl E, Diez-Canesco D, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204-7. Doi: 10.1111/jns.12382.

  51. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020 Jun 25;382(26):2574-6. Doi: 10.1056/NEJMc2009191.

  52. Juliao Caamaño DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020;77:230-2. Doi: 10.1016/j.jocn.2020.05.016

  53. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranial is in COVID-19. Neurology. 2020;95(5):e601-e605. Doi: 10.1212/WNL.0000000000009619.

  54. Reyes-Bueno JA, García-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Martínez-Tomás C, et al. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020 Sep;27(9):1759-61. Doi: 10.1111/ENE.14383

  55. Fernandez-Dominguez J, Ameijide-Sanluis E, Garcia-Cabo C, Garcia-Rodriguez R, Mateos V. Miller–Fisher‑like syndrome related to SARS‑CoV‑2 infection (COVID 19). J Neurol. 2020;267(9):2495-6. Doi: https://doi.org/10.1007/s00415-020-09912-2

  56. Wei H, Yin H, Huang M, Guo Z. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267(5):1550-3. Doi: https://doi.org/10.1007/s00415-020-09773-9

  57. Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID-19. Emerg Infect Dis. 2020;26(7):1618-20. Doi: http://doi.org/10.3201/eid2607.200445




2020     |     www.medigraphic.com